
Take a quick look at everything you may have missed in August, including the top FDA approvals and latest clinical updates.

Take a quick look at everything you may have missed in August, including the top FDA approvals and latest clinical updates.

Most patients meet PMOS in a primary care office first. Our experts map the referral threshold and argue insulin resistance — not just androgens — should drive how aggressively PCPs treat.

Ovarian ultrasound doesn't apply to teens. Our experts walk through the 2-criteria threshold for adolescents, the "at risk" category, and why untreated menstrual irregularity carries real long-term consequences.

A global Lancet consensus just renamed PCOS to PMOS. Our experts explain why the shift moves care beyond the ovaries — and what it means for how clinicians talk to patients today.

Back-to-school visits close vaccine gaps fast—MMR, Tdap, meningococcal, HPV, plus flu/RSV prevention before illnesses surge.


Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Bradley Peterson, MD, discusses when pediatricians should consider adding a second treatment for pediatric anxiety and why improvement may continue well beyond the first 3 months of therapy.

The AAP's updated clinical report revises screening timelines, ferritin thresholds, and treatment protocols for pediatric iron deficiency and iron deficiency anemia.

CDC has declared the Nara Organics infant botulism outbreak over; genetic testing ties it to the 2025 ByHeart outbreak.

Bradley Peterson, MD, discusses how treatment preferences, access, tolerability, and patient characteristics can guide pediatric anxiety care when CBT and medication provide similar overall benefits.

Lori Handy, MD, says vaccine conversations with hesitant families should prioritize trust, follow-up, and the benefits for the individual child.

CBT and fluoxetine both reduced pediatric anxiety, while starting with CBT before adding medication showed advantages on several outcomes.

The FDA has approved Tivicay PD (dolutegravir) to treat HIV-1 in newborns from birth, based on IMPAACT 2023 pharmacokinetic and safety data.

FDA De Novo authorization establishes Avulux lenses as an option for migraine-associated light sensitivity in patients aged 12 years and older.

FDA authorized Abbott's Libre Duo 10 Day, the first wearable that continuously tracks glucose and ketones, for patients 2 and older with diabetes.

FDA approved nipocalimab (Imaavy) for wAIHA in patients 12 and older, based on Phase 2/3 ENERGY trial data on durable hemoglobin response.

Nine societies outline 6 domains of hospital-level sepsis strategies, from rapid blood culture diagnostics to daily toothbrushing protocols.

Phase 3 data show lebrikizumab improved skin clearance, itch, and quality of life in children with moderate-to-severe atopic dermatitis.

Pediatric psychiatric diagnoses and treatment rose above prepandemic levels, with notable increases in medication initiation and care among girls.

Higher parent smartphone use was associated with slower vocabulary growth from ages 5 to 7 years in a prospective cohort study.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Pediatric mental health treatment exceeded prepandemic levels, with antidepressant initiation rising sharply among girls after COVID-19.

John Walkup, MD, says collaborative care, education, and psychiatric consultation can help pediatricians manage children's mental health needs.

John Walkup, MD, says pediatricians can address growing mental health needs by identifying risk factors and providing guidance early in childhood.

The AAP recommends annual flu vaccination for all children aged 6 months and older and updates antiviral guidance for the 2026–2027 season.

Infliximab or steroids may be more effective than anakinra as adjunctive therapy for children with MIS-C who do not respond to IVIG.

FDA granted priority review to Teva's ecopipam for pediatric Tourette syndrome, backed by phase 3 data showing reduced relapse risk.

Lisa Swanson, MD, describes AD as fundamentally unpredictable — a roller coaster of flares and quiet stretches that can wear down patients and families alike.

Lisa Swanson, MD, returns to diagnostic pitfalls, describing a presentation she sees often: AD in the crease of an infant's neck, which is frequently misdiagnosed as a yeast infection.